Close

melan-A

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Protein melan-A also known as melanoma antigen recognized by T cells 1 or MART-1 is a protein that in humans is encoded by the MLANA gene. A fragment of the protein, usually consisting of the nine amino acids 27 to 35, is bound by MHC class I complexes which present it to T cells of the immune system. These complexes can be found on the surface of melanoma cells. Decameric peptides (26-35) are being investigated as cancer vaccines.

Associated Disease
  • TCR Vector Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-L072 Human anti-MLANA (ELAGIGILTV) T Cell Receptor, pLXSN Human Human ELAGIGILTV HLA-A2 retroviral vector   Add to Cart   Datasheet
TCR-L071Z Human anti-melan-A T cell receptor, pCDTCR1 Human Human ELAGIGILTV HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-L251 Human anti-melan-A T cell receptor (SW-M1-9), pCDTCR1 Human SW-M1-9 Human ELAGIGILTV: HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-L252 Human anti-melan-A T cell receptor (SW-M1-29), pCDTCR1 Human SW-M1-29 Human ELAGIGILTV: HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-L253 Human anti-melan-A T cell receptor (SW-M1-54), pCDTCR1 Human SW-M1-54 Human ELAGIGILTV: HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-L254 Human anti-melan-A T cell receptor (SW-M1-66), pCDTCR1 Human SW-M1-66 Human ELAGIGILTV: HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-L255 Human anti-melan-A T cell receptor (SW-M1-67), pCDTCR1 Human SW-M1-67 Human ELAGIGILTV: HLA-A*0201 Lentiviral   Add to Cart   Datasheet
XS-0623-LX14 Anti-Melan-A (PD1/28-F4 TCR) T cell receptor, pCDTCR1 Vector Human F4 Human AA26–35 HLA-A2 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.